Simplex Trading’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Simplex Trading’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,026	Closed	-$9K	–	8845
2020 Q1	$9K	Buy	+1,026	New	+$10.1K	﹤0.01%	6577
2018 Q3	–	Sell	-358	Closed	-$6K	–	8447
2018 Q2	$6K	Sell	358 -811	-69%	-$16.3K	﹤0.01%	6663
2018 Q1	$24K	Buy	+1,169	New	+$22.9K	﹤0.01%	3198
2017 Q4	–	Sell	-31	Closed	–	–	7070
2017 Q3	$0	Sell	31 -274	-90%	-$6.57K	﹤0.01%	7027
2017 Q2	$8K	Buy	+305	New	+$9.87K	﹤0.01%	4231
2016 Q3	–	Sell	-2,720	Closed	-$175K	–	6798
2016 Q2	$175K	Sell	2,720 -2,811	-51%	-$173K	0.01%	1082
2016 Q1	$400K	Buy	+5,531	New	+$410K	0.03%	537

Simplex Trading's ZBIO Position: Q2 2020 in Review

Simplex Trading sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q2 2020, closing a stake of 1,026 shares — an estimated $9K sold.

Simplex Trading first reported a position in ZBIO in Q1 2016 and held it in 7 quarters. The position peaked at $400K in Q1 2016. 0 funds tracked by Wall St. Rank hold ZBIO as of Q2 2020.

Simplex Trading reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q2 2020 after selling out during the quarter.
Simplex Trading sold 1,026 ProShares UltraPro Short NASDAQ Biotechnology shares in Q2 2020, an estimated $9K.
Simplex Trading first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q1 2016 and held it in 7 quarters.
Simplex Trading's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $400K in Q1 2016.
0 funds tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q2 2020.

Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.